Navigation Links
Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke
Date:5/26/2010

Physicians now have more options in tailoring treatments for patients at risk for stroke.

(Vocus) May 26, 2010 -- After nine years of investigation, the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST), conducted in part by University at Buffalo Neurosurgery, shows that two different procedures designed to prevent future strokes are safe and effective overall. In the trial of 2,502 participants, carotid endarterectomy (CEA), a surgical procedure considered the gold standard prevention treatment, was compared to carotid artery stenting (CAS), a newer and less invasive procedure that involves expanding a small device in the artery to widen the blocked area and capture any dislodged plaque. The trial was funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH). Results of the study appear today in the online first edition of the New England Journal of Medicine.*

The CREST trial was performed at 117 medical centers in the United States and Canada and is considered one of the largest randomized stroke trials ever conducted. University at Buffalo Neurosurgery played a key role in the investigation as a leading enroller and the designated CAS training site for more than 200 surgeons, neurosurgeons, radiologists, and cardiologists participating in the study. University at Buffalo Neurosurgery is one of the busiest neuroendovascular laboratories and one of the most experienced and successful practitioners of carotid stenting in the world.

Results of the CREST trial show that the overall safety and efficacy of the two pro
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Landmark Textbook Aims to Improve Clinician, Consumer Understanding of Lesbian Health
2. DNC Chairman Tim Kaine Calls Senate Vote Historic, Says Landmark Health Reform Bill Is a Victory for the American People
3. Senate Passes Landmark Health Care Reform Bill
4. New edition of landmark stroke textbook
5. California to Examine Health Impacts of Landmark Cap-and-Trade Program
6. Foodborne Illness Costs U.S. $152 Billion Annually, Landmark Report Estimates
7. Landmark Legal Foundation to File Suit to Stop Presidents Health Plan if Slaughter Rule is Used
8. China's Forbidden City Leads Landmark Climate Action for Earth Hour
9. Endometriosis Foundation of America to Present Landmark Scientific Symposium in NYC
10. Drug Information Association (DIA) Announces New Clinical Safety and Pharmacovigilance Certificate Program
11. FDA Issues Guidance to Help Streamline Medical Device Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 6Webs.com ... The simple to read reviews and comprehensive comparisons make ... impartial home security reviews. 6Webs.com just recently finished conducting ... system providers. , Tim Smythe from 6Webs.com reports, "There ... systems due to their ease of use, expandability and ...
(Date:5/18/2013)... Mexico, DF (PRWEB) May 18, 2013 ... by leading ayurvedic education institution in the West. Program ... Learning education. , Ayurveda is a healing modality practiced ... Ayurvedica ), it is considered that health begins when ... a profound understanding of their individual needs. Ayurveda aims ...
(Date:5/18/2013)... IL (PRWEB) May 18, 2013 The ... Oregon Gov. John A. Kitzhaber, M.D., (D) to sign ... law by prohibiting minors under the age of 18 ... would become the third state in the nation to ... have enacted similar indoor tanning bans for minors. Nationwide, ...
(Date:5/18/2013)... Ohio (PRWEB) May 18, 2013 ... Annual Conference, on May 17-22 in Austin, TX ... gather for educational and networking opportunities. , ... brushes, flexible scope repair capabilities and ... with valuable educational information on proper instrument care ...
(Date:5/18/2013)... John Ravera, D.D.S., a Newport Beach ... new member to his dental team, Courtney Marino. , Marino ... for over 10 years. She received her degree from West ... a member of Sigma Pi Alpha, a national honor society ... with patients of all ages, helping them understand the importance ...
Breaking Medicine News(10 mins):Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2
... babies for the presence of a common infection was approved ... streptococcus// is a common infection that is passed from mother ... or even death. ,Although all women are tested ... leave some babies at risk for contracting an infection from ...
... certain premature babies to inhale small amounts of nitric ... bronchopulmonary dysplasia, according// to the results of two studies ... born with this condition each year in the United ... are too immature to mix inhaled air properly with ...
... considering becoming pregnant could prevent preeclampsia if they started ... following it up// during the first three months of ... blood pressure shoots up dangerously and could prove lethal ... of Pittsburgh say that this condition could be avoided ...
... the cornerstones of managing type 2 diabetes. But few ... ,Now, a new systematic review shows that exercise ... sensitivity to insulin, and decreases blood lipids (fats) while ... 2 diabetes is an increasing problem in Western societies ...
... of Medicine, University of California, Los Angels and Valencia, ... developed an alternative to the conventional epilepsy treatment. ... study and the clinical trails show that it has ... nerve that prevents seizures is stimulated to inhibit epilepsy. ...
... by Linda Chaudron, M.D., an assistant professor of psychiatry, pediatrics ... is a disorder which is fast rising among new mothers. ... screened for a period of 12 months after childbirth. Such ... as the symptoms, develop throughout the year. Only if ...
Cached Medicine News:Health News:FDA Approves New Test For Screening Infection In Babies 2Health News:FDA Approves New Test For Screening Infection In Babies 3Health News:Nitric Oxide Could Benefit Premature Babies 2Health News:Using Multivitamins Before And After Conception Averts Preeclampsia 2Health News:Using Multivitamins Before And After Conception Averts Preeclampsia 3Health News:Exercise in Itself Improves Blood Glucose Control in Type 2 Diabetes 2Health News:Exercise in Itself Improves Blood Glucose Control in Type 2 Diabetes 3Health News:Alternative to the Conventional Seizure Treatment 2Health News:Early Diagnosis of Postpartum Depression Is Very Essential Among New Mothers 2
(Date:5/17/2013)... , May 17, 2013  Boston Scientific Corporation (NYSE: ... the annual EuroPCR Scientific Program May 21-24 in ... to present a particularly rich and diversified set of ... Dawkins , M.D., global chief medical officer, Boston ... be presented, including the NG PROMUS trial, which evaluated ...
(Date:5/16/2013)...  PTC Therapeutics, Inc., today announced that it has ... U.S. Securities and Exchange Commission ("SEC") relating to the ... number of shares to be offered and the price ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) J.P. ... managers for the offering. Cowen and Company is acting ...
(Date:5/16/2013)... and SYDNEY , May 16, 2013 /PRNewswire/ ... HIN), a leading innovator of less invasive, miniaturized circulatory support ... today announced that CEO Doug Godshall ... Conference at 11:00 a.m. EDT on Monday, May 20, 2013.  ... Sheraton New York Hotel. A live webcast of ...
Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
... biotechnology company,developing clinical stage treatments for cancer and ... from its Phase II,clinical trial of OncoVEX GM-CSF, ... at the 2008 Annual Meeting of the American,Society ... Clinical Trial Details, Phase II Trial Design: ...
... May 31 Millennium Pharmaceuticals, The Takeda,Oncology Company, ... trials of VELCADE based therapies that showed consistently ... diagnosed multiple,myeloma (MM). CR is one of the ... selected for oral presentation at the American Society,of ...
Cached Medicine Technology:BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 4Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma 2Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma 3Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma 4Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma 5Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma 6Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma 7
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,409-7) or contact custom...
... samples of moderate viscosity and density. Proven ergonomic design reduces hand fatigue, ... Volume Range (ul) ... 1.0~1.5 Imprecision(%) ... 10 ...
... is a fully adjustable, air-displacement pipette with ... the latest member of the Pipetman family, ... accuracy, and precision. We also added a ... our customers. Eight models cover the full ...
... Finnpipette Digital offers improved ergonomics for ... handle, modified grippy finger rest and ... comfort and efficiency. Finnpipette Digitals also ... gearing mechanism (pat. pend.) and super ...
Medicine Products: